NanoViricides, Inc. Reports At NanoBiotech 2006 Conference: AviFluCide-I(TM) And FluCide-I(TM) Best Drugs Against H5N1 And Common Influenzas, Respectively

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc., (Pink Sheets: NNVC) Dr. Anil Diwan, Company President and Chairman, provided a synthesis of the results so far obtained against common influenza (H1N1) animal studies and avian flu (H5N1) cell culture studies at the NanoBiotech 2006 Conference in Boston on November 17th.

MORE ON THIS TOPIC